Michael W. Pill

629 total citations
10 papers, 531 citations indexed

About

Michael W. Pill is a scholar working on Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Economics and Econometrics. According to data from OpenAlex, Michael W. Pill has authored 10 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pathology and Forensic Medicine, 5 papers in Public Health, Environmental and Occupational Health and 3 papers in Economics and Econometrics. Recurrent topics in Michael W. Pill's work include Multiple Sclerosis Research Studies (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Michael W. Pill is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Acute Lymphoblastic Leukemia research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Michael W. Pill collaborates with scholars based in United States and Spain. Michael W. Pill's co-authors include Christina Caon, Leigh Ann White, Joseph Menzin, Christine Nichols, Mark I. Friedman, Eli O. Meltzer, James C. Norton, Doral Fredericks, Grant H. Skrepnek and Ajay Singh and has published in prestigious journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Journal of Medical Economics and Journal of Managed Care & Specialty Pharmacy.

In The Last Decade

Michael W. Pill

10 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Pill United States 9 285 93 92 88 87 10 531
M Benford United Kingdom 4 54 0.2× 56 0.6× 79 0.9× 65 0.7× 16 0.2× 9 610
Bernadette Porter United Kingdom 11 304 1.1× 108 1.2× 171 1.9× 31 0.4× 14 0.2× 32 550
Jonathan Hosey United States 3 433 1.5× 127 1.4× 89 1.0× 121 1.4× 88 1.0× 5 505
Huah Shin Ng Australia 14 167 0.6× 45 0.5× 33 0.4× 162 1.8× 60 0.7× 36 548
Shien Guo United States 16 158 0.6× 41 0.4× 48 0.5× 170 1.9× 61 0.7× 61 571
Neetu Agashivala United States 14 414 1.5× 105 1.1× 101 1.1× 94 1.1× 111 1.3× 30 602
Delia Colombo Italy 11 159 0.6× 11 0.1× 183 2.0× 20 0.2× 50 0.6× 23 566
José M.A. Wijnands Canada 14 418 1.5× 137 1.5× 152 1.7× 47 0.5× 24 0.3× 25 612
Alicia Ai-cia Cheak Singapore 8 49 0.2× 22 0.2× 300 3.3× 40 0.5× 45 0.5× 10 554
Jenny M. Norlin Sweden 14 29 0.1× 81 0.9× 35 0.4× 44 0.5× 23 0.3× 43 491

Countries citing papers authored by Michael W. Pill

Since Specialization
Citations

This map shows the geographic impact of Michael W. Pill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Pill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Pill more than expected).

Fields of papers citing papers by Michael W. Pill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Pill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Pill. The network helps show where Michael W. Pill may publish in the future.

Co-authorship network of co-authors of Michael W. Pill

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Pill. A scholar is included among the top collaborators of Michael W. Pill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Pill. Michael W. Pill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Fredericks, Doral, et al.. (2017). Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden.. PubMed. 23(5 Suppl). S83–S92. 54 indexed citations
2.
Iyer, Ravi, et al.. (2016). Quantifying Differences in Health Care Consumption for the Management of Multiple Sclerosis Within Privately and Publicly Insured Health Care Programs. Journal of Managed Care & Specialty Pharmacy. 22(12). 1385–1391. 14 indexed citations
3.
Joyce, Amie T., Shravanthi R. Gandra, Kathleen M. Fox, Timothy W. Smith, & Michael W. Pill. (2013). National and regional dose escalation and cost of tumor necrosis factor blocker therapy in biologic-naïve rheumatoid arthritis patients in US health plans. Journal of Medical Economics. 17(1). 1–10. 17 indexed citations
4.
Menzin, Joseph, Christina Caon, Christine Nichols, et al.. (2013). Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis. Journal of Managed Care Pharmacy. 19(1 Supp A). S24–S40. 178 indexed citations
5.
Skrepnek, Grant H., et al.. (2013). Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies. Journal of Managed Care Pharmacy. 19(1 Supp A). S41–S53. 40 indexed citations
6.
Brandes, David, Fadia T. Shaya, & Michael W. Pill. (2010). Quantifying the role of natalizumab in health and economic outcomes in multiple sclerosis.. PubMed. 16(6 Suppl). S171–7. 7 indexed citations
7.
Pill, Michael W., et al.. (2009). A claims-based view of health care charges and utilization for commercially insured patients with osteoarthritis.. PubMed. 18(12). 44–50. 30 indexed citations
8.
Pill, Michael W., et al.. (2007). Descriptive Analysis of the Direct Medical Costs of Multiple Sclerosis in 2004 Using Administrative Claims in a Large Nationwide Database. Journal of Managed Care Pharmacy. 13(1). 44–52. 91 indexed citations
9.
Meltzer, Eli O., et al.. (2004). Allergic Rhinitis, Asthma, and Rhinosinusitis: Diseases of the Integrated Airway. Journal of Managed Care Pharmacy. 10(4). 310–317. 66 indexed citations
10.
Pill, Michael W., et al.. (1997). Suspected Acute Interstitial Nephritis Induced by Piperacillin‐Tazobactam. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(1). 166–169. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026